Recommendations for early empiric antiviral treatment in persons with suspected influenza who are at increased risk of developing severe disease

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Recommendations for early empiric antiviral treatment in persons with suspected influenza who are at increased risk of developing severe disease

Published Date:

10/19/09

Series:

HAN ; 299

Language:

English

[PDF-746.49 KB]

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Description:

Monday, October 19, 2009, 13:51 EDT (1:51 PM EDT) CDCHAN-00299-2009-10-19-ADV-N Summary Recommendations: When treatment of influenza is indicated in a patient with suspected influenza, health care providers should initiate empiric antiviral treatment as soon as possible. Waiting for laboratory confirmation of influenza to begin treatment with antiviral drugs is not necessary. Patients with a negative rapid influenza diagnostic test should be considered for treatment if clinically indicated because a negative rapid influenza test result does not rule out influenza virus infection. The sensitivity of rapid influenza diagnostic tests for 2009 H1N1 virus can range from 10% to 70%, indicating that false negative results occur frequently.

Subject:

[+]

Document Type:

HAN Health Advisory

Place as Subject:

United States

Collection(s):

Health Alert Network (HAN)

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Frequently asked influenza flu) questions: 2020-2021 Season

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)

Published Date:

June 26, 2020

File Type:

[PDF - 112.22 KB]
Frequently asked influenza (flu) questions: 2020-2021 season

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)

Published Date:

June 5, 2020

File Type:

[PDF - 188.48 KB]
Pandemic vaccine program : distribution, tracking, and monitoring

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)

Published Date:

04/20/20

Description:

During a pandemic, CDC will scale up existing vaccine distribution, tracking, and monitoring systems to support the response.Interim pandemic distribution plan, 04/20/20pandemic-influenza-vaccine-distribution-9p-508.pdf

File Type:

[PDF - 1.11 MB]
National Infant Immunization Week : April 25-May 2, 2020 : the power to protect

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)

Published Date:

April 1, 2020

Series:

National Infant Immunization Week

Description:

National Infant Immunization Week (NIIW) is a yearly observance highlighting the importance of protecting children two years and younger from vaccine-preventable diseases (VPDs). It’s also a time to showcase the achievements of immunization program...

File Type:

[PNG - 180.44 KB]
Semana Nacional de la Inmunización Infantil : 27 de abril - 4 de mayo del 2019 : con salud, todo es posible. Vacune a sus hijos

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.)

Published Date:

1 de abril 2020

Series:

National Infant Immunization Week

Description:

#ivax2protectNIIW_Icon_Logo_BannerStacked_Color_Spanish.png

File Type:

[PNG - 247.40 KB]